Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -889.92% is 1087% below its 5-year average of -75.00%, near the low end of its 5-year range (-889.92%–-38.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 202.60% below its 12-month average of -294.09%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -889.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-889.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-294.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-87.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-75.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-202.60%
CURRENT VS 3Y AVG
-918.63%
CURRENT VS 5Y AVG
-1086.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 763 covered companies
CURRENT VS SECTOR MEDIAN
-2459.46%
vs the sector median at left
Passage Bio, Inc.
Market Cap
$13.24M
Return on Invested Capital (ROIC)
-889.92%
TTM Avg
-294.09%
3Y Avg
-87.37%
5Y Avg
-75.00%
Market Cap
$13.51M
Return on Invested Capital (ROIC)
-28.72%
TTM Avg
-40.11%
3Y Avg
-38.90%
5Y Avg
-32.17%
Market Cap
$13.66M
Return on Invested Capital (ROIC)
-57.53%
TTM Avg
-660.45%
3Y Avg
-553.22%
5Y Avg
-396.73%
Market Cap
$12.78M
Return on Invested Capital (ROIC)
-74.94%
TTM Avg
-273.26%
3Y Avg
-277.38%
5Y Avg
-186.51%
Market Cap
$12.77M
Return on Invested Capital (ROIC)
-43.31%
TTM Avg
-42.56%
3Y Avg
-55.36%
5Y Avg
-44.03%
Market Cap
$13.71M
Return on Invested Capital (ROIC)
-91.74%
TTM Avg
-119.31%
3Y Avg
-112.64%
5Y Avg
-88.90%
Market Cap
$13.74M
Return on Invested Capital (ROIC)
-67.62%
TTM Avg
-48.11%
3Y Avg
-41.05%
5Y Avg
-37.60%
Market Cap
$13.86M
Return on Invested Capital (ROIC)
-157.90%
TTM Avg
-186.85%
3Y Avg
-152.06%
5Y Avg
-115.52%
Market Cap
$12.52M
Return on Invested Capital (ROIC)
-203.50%
TTM Avg
-154.20%
3Y Avg
-205.70%
5Y Avg
-169.89%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Passage Bio, Inc. (PASG) | $13.24M | -889.92% | -294.09% | -87.37% | -75.00% |
| Optimi Health Corp. (OPTH)vs › | $13.51M | -28.72% | -40.11% | -38.90% | -32.17% |
| Vyome Holdings, Inc. (HIND)vs › | $13.66M | -57.53% | -660.45% | -553.22% | -396.73% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.78M | -74.94% | -273.26% | -277.38% | -186.51% |
| Cytosorbents Corporation (CTSO)vs › | $12.77M | -43.31% | -42.56% | -55.36% | -44.03% |
| IN8bio, Inc. (INAB)vs › | $13.71M | -91.74% | -119.31% | -112.64% | -88.90% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.74M | -67.62% | -48.11% | -41.05% | -37.60% |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | -157.90% | -186.85% | -152.06% | -115.52% |
| Dare Bioscience, Inc. (DARE)vs › | $12.52M | -203.50% | -154.20% | -205.70% | -169.89% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.32M | -86.22% | -227.24% | -220.51% | -220.51% |
ROIC
-889.9%
ROE
-810.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -889.92% |
| 2026-03-31 | -255.03% |
| 2025-12-31 | -125.76% |
| 2025-09-30 | -95.77% |
| 2025-06-30 | -103.99% |
| 2025-03-31 | -100.92% |
| 2024-12-31 | -84.77% |
| 2024-09-30 | -78.67% |
| 2024-06-30 | -73.05% |
| 2024-03-31 | -70.92% |
| 2023-12-31 | -80.76% |
| 2023-09-30 | -79.08% |
| 2023-06-30 | -67.33% |
| 2023-03-31 | -67.07% |
| 2022-12-31 | -61.45% |
| 2022-09-30 | -64.93% |
| 2022-06-30 | -66.43% |
| 2022-03-31 | -62.02% |
| 2021-12-31 | -57.05% |
| 2021-09-30 | -47.09% |
| 2021-06-30 | -38.00% |
| 2021-03-31 | -30.05% |
| 2020-12-31 | -36.80% |
| 2020-09-30 | -25.75% |
| 2020-06-30 | -19.36% |
| 2020-03-31 | -13.15% |
| 2019-12-31 | -21.26% |
| 2019-09-30 | -16.04% |
